Literature DB >> 32082

[Hormone and metabolic profile in diabetic hyperosomolar coma. Plasma insulin response to intravenous tolbutamide (author's transl)].

M Chupin, B Charbonnel, B Dubin, J P Remi, J Guillon.   

Abstract

Fifteen patients with non-ketotic hyperosmolar diabetic coma were investigated and compared with ketoacidotic patients. Basal plasma insulin levels were low in all patients (14.8 +/- 1.0 micronU/ml in hyperosmolar coma, 11.0 +/- 1.3 in keto-acidosis), but insulin level increased after intravenous tolbutamide (between 30 and 105 micronU/ml) in eight hyperosmolar comas. Insulin showed no increase in seven hyperosmolar comas and in none of the ketoacidotic patients. In hyperosmolar coma plasma free fatty acids (1710 +/- 197 micronEq/1), triglycerides (3,4 +/- 0,4 g/1) and cortisol levels (49,7 +/- 9,0 microgram/100 ml) were increased, must as in keto-acidosis. Growth hormone (1,7 +/- 0,1 ng/ml) was normal, unlike the case in keto-acidosis. Plasma lactate concentrations were elevated and account for the frequent mild acidosis found in hyperosmolar coma. In spite of the low peripheral "insulin/glycemia ratio", the positive response to tolbutamide in half of the hyperosmolar cases suggests a less complete pancreatic deficiency than in keto-acidosis. The plasma high free fatty acid and triglyceride levels suggest that the lack of ketosis is not due to inhibition of lipolysis but could be a consequence of inhibition of hepatic ketogenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 32082

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  2 in total

1.  Reflections on the anion gap in hyperglycemia.

Authors:  J Varon; M B Jacobs; C A Mahoney
Journal:  West J Med       Date:  1992-12

2.  C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma.

Authors:  M Chupin; B Charbonnel; F Chupin
Journal:  Acta Diabetol Lat       Date:  1981 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.